Literature DB >> 26700601

Inter-observer agreement of MRI-based tumor delineation for preoperative radiotherapy boost in locally advanced rectal cancer.

Johannes Peter Maarten Burbach1, Jean-Paul Johannes Kleijnen2, Onne Reerink3, Enrica Seravalli2, Marielle E P Philippens2, Tim Schakel2, Bram van Asselen2, Bas W Raaymakers2, Marco van Vulpen2, Martijn Intven2.   

Abstract

BACKGROUND: While surgery remains the cornerstone of rectal cancer treatment, organ-preservation is upcoming. Therefore, neo-adjuvant treatment should be optimized. By escalating doses, response can be increased. To limit toxicity of boost, accurate gross tumor volume (GTV) definition is required. MRI, especially undeformed fast spin echo diffusion-weighted MRI (DWI), looks promising for delineation. However, inconsistencies between observers should be quantified before clinical implementation. We aim to find which MRI sequence (T2w, DWI or combination) is optimal and clinically useful for GTV definition by evaluating inter-observer agreement.
METHODS: Locally advanced rectal cancer patients (tumors <10 cm from anal verge) were scanned on 3T MRI transverse T2w and DWI (b=800 s/mm(2)). Three independent observers delineated T2w, DWI and combination (Combi) after training-set. Volumes, conformity index (CI), and maximum Hausdorff distance (HD) were calculated between any observer-pair per patient per modality.
RESULTS: Twenty-four consecutive patients were included. One patient had cT2 (4.2%), 19 cT3 (79.1%) and 4 cT4 (16.7%), with 2 clinical node negative (8.3%), 4 cN1 (16.7%), and 18 cN2 (75.0%) on MRI. From 24 patients, 70 sequences were available (24x T2, 23x DWI, and 23x Combi). Between observers, no significant volume differences were observed per modality. T2 showed significantly largest volumes compared to DWI (mean difference 19.85 ml, SD 17.42, p<0.0001) and Combi (mean difference 7.16 ml, SD 11.58, p<0.0001). Mean CI was 0.70, 0.71 and 0.69 for T2, DWI and Combi respectively (p>0.61). Average HD was largest on T2 (18.60mm, max 31.40 mm, min 9.20mm). DISCUSSION: Delineation on DWI resulted in delineation of the smallest volumes with similar consistency and mean distances, but with slightly lower Hausdorff distances compared to T2 and Combi. However, with lack of a gold standard it remains difficult to establish if delineations also represent true tumor. Study strengths were DWI adaptation to exclude geometrical distortions and training-set. DWI shows great potential for delineation purposes as long as sufficient experience exists and geometrical distortions are eliminated.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Inter-observer agreement; MRI; Radiotherapy; Rectal cancer

Mesh:

Year:  2015        PMID: 26700601     DOI: 10.1016/j.radonc.2015.10.030

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

Review 1.  Biological imaging in clinical oncology: radiation therapy based on functional imaging.

Authors:  Yo-Liang Lai; Chun-Yi Wu; K S Clifford Chao
Journal:  Int J Clin Oncol       Date:  2016-07-06       Impact factor: 3.402

2.  Europium-phenolic network coated BaGdF5 nanocomposites for tri-modal computed tomography/magnetic resonance/luminescence imaging.

Authors:  Wei Zhu; Shuang Liang; Jing Wang; Zhe Yang; Li Zhang; Tianmeng Yuan; Zushun Xu; Haibo Xu; Penghui Li
Journal:  J Mater Sci Mater Med       Date:  2017-03-30       Impact factor: 3.896

3.  Manual and semi-automated delineation of locally advanced rectal cancer subvolumes with diffusion-weighted MRI.

Authors:  Nathan Hearn; William Bugg; Anthony Chan; Dinesh Vignarajah; Katelyn Cahill; Daisy Atwell; Jim Lagopoulos; Myo Min
Journal:  Br J Radiol       Date:  2020-09-02       Impact factor: 3.039

4.  The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal.

Authors:  Davide Prezzi; Ramin Mandegaran; Sofia Gourtsoyianni; Katarzyna Owczarczyk; Andrew Gaya; Robert Glynne-Jones; Vicky Goh
Journal:  Eur Radiol       Date:  2017-11-13       Impact factor: 5.315

5.  MR guided high intensity focused ultrasound (MRgHIFU) for treating recurrent gynaecological tumours: a pilot feasibility study.

Authors:  Sharon L Giles; Georgios Imseeh; Ian Rivens; Gail R Ter Haar; Alexandra Taylor; Nandita M deSouza
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

Review 6.  Realizing the potential of magnetic resonance image guided radiotherapy in gynaecological and rectal cancer.

Authors:  Ingrid M White; Erica Scurr; Andreas Wetscherek; Gina Brown; Aslam Sohaib; Simeon Nill; Uwe Oelfke; David Dearnaley; Susan Lalondrelle; Shreerang Bhide
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

7.  Locally advanced rectal cancer: 3D diffusion-prepared stimulated-echo turbo spin-echo versus 2D diffusion-weighted echo-planar imaging.

Authors:  Qinwei Zhang; Petra J van Houdt; Doenja M J Lambregts; Baukelien van Triest; Marnix P M Kop; Bram F Coolen; Gustav J Strijkers; Uulke A van der Heide; Aart J Nederveen
Journal:  Eur Radiol Exp       Date:  2020-02-07

8.  Evaluation of diffusion weighted imaging for tumor delineation in head-and-neck radiotherapy by comparison with automatically segmented 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Tim Schakel; Boris Peltenburg; Jan-Willem Dankbaar; Carlos E Cardenas; Michalis Aristophanous; Chris H J Terhaard; Johannes M Hoogduin; Marielle E P Philippens
Journal:  Phys Imaging Radiat Oncol       Date:  2018-01-30

9.  Feasibility of magnetic resonance imaging-only rectum radiotherapy with a commercial synthetic computed tomography generation solution.

Authors:  Matteo Maspero; Marcus D Tyyger; Rob H N Tijssen; Peter R Seevinck; Martijn P W Intven; Cornelis A T van den Berg
Journal:  Phys Imaging Radiat Oncol       Date:  2018-10-02

10.  Interobserver variability in target volume delineation for CT/MRI simulation and MRI-guided adaptive radiotherapy in rectal cancer.

Authors:  Ingrid White; Arabella Hunt; Thomas Bird; Sarah Settatree; Heba Soliman; Dualta Mcquaid; David Dearnaley; Susan Lalondrelle; Shree Bhide
Journal:  Br J Radiol       Date:  2021-11-02       Impact factor: 3.039

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.